Brainreader
About Brainreader
Brainreader is a Danish healthcare AI company that specializes in quantitative brain MRI analysis through its flagship software, Neuroreader®. Founded in 2011, the company develops FDA-cleared and CE-marked medical device software that provides clinicians with objective, reproducible brain volumetric data. Neuroreader® automates the analysis of 3D T1-weighted MRI scans, quantifying over 65 to 83 specific brain structures, including the hippocampus, cortical lobes, and ventricles, in under 10 minutes. This rapid analysis helps physicians in the early detection, diagnosis, and monitoring of neurodegenerative diseases by identifying subtle atrophy patterns that may be invisible to the human eye.
For physicians, Neuroreader® serves as a clinical decision-support tool, offering objective data in the form of volumes (mL), percentiles, and Z-scores, and enabling longitudinal tracking of brain volume changes over time. This quantitative insight is crucial for conditions such as Alzheimer’s disease and dementia, mild cognitive impairment (MCI), traumatic brain injury (TBI), and epilepsy. The software integrates seamlessly into existing PACS or can be used via web upload, streamlining workflow without requiring extensive staff retraining or additional patient time. By providing accurate and actionable insights, Brainreader aims to empower healthcare professionals to make more informed clinical decisions, design effective treatment plans, and ultimately improve patient outcomes.
Focus Areas
Business Intelligence
| Key Investors | Dahlgren Capital, Investo Capital, CBC Investment Group, Bevica Foundation, Insero, Syddansk Innovation |
| Partnerships | INFINITT North America (2022) |
| Technology | Cloud-based platform, AI-powered deep learning algorithms, integrates with PACS, processes DICOM images from MRI scans |
| FDA Clearances | 1 (Neuroreader®) cleared products (estimated) |
What Physicians Need to Know
For physicians, Brainreader's Neuroreaderu00ae offers a powerful tool for earlier and more confident diagnosis and monitoring of neurodegenerative diseases, TBI, and epilepsy. The automated, quantitative reports, delivered in under 10 minutes, can significantly reduce the time to diagnosis and free up valuable physician time. The objective data and longitudinal tracking capabilities allow for better differentiation between conditions with overlapping symptoms, more informed treatment planning, and clearer communication with patients and their families about disease progression. Integrating Neuroreaderu00ae into existing MRI workflows is designed to be seamless, whether through web-based access, a mediation server, or direct PACS integration.
Brainreader's Neuroreaderu00ae is designed for seamless integration into existing clinical workflows. It supports PACS integration for automated image routing and report delivery, and also offers secure web portal access and mediation server options. This flexibility allows for easy deployment across various clinical and enterprise environments, including single-site clinics and large health systems.
What the Web Says
Brainreader is a Danish medical device company that developed Neuroreader, FDA-cleared and CE marked software for analyzing MRI scans to detect changes in brain volume. The software aims to assist in the early diagnosis of neurodegenerative diseases like Alzheimer's, epilepsy, and depression, as well as traumatic brain injuries. Neuroreader is designed to provide fast and accurate measurements of brain structures, significantly reducing the time radiologists spend on analyzing MRI scans.
Overall: PositiveStrengths
- Fast and accurate detection of brain volume changes compared to traditional methods.
- FDA-cleared and CE marked software, providing a level of regulatory approval that competitors may lack.
- Measures a large number of specific brain structures (up to 83 in customizable reports).
- Reduces MRI read times for radiologists from approximately 24 minutes to 10 minutes or less.
- Helps clinicians identify early and sensitive biomarkers of neurodegenerative diseases.
- Provides objective analysis by comparing brain volumes against normative datasets, eliminating bias.
Limitations
- Limited information available regarding company/employer reviews on major platforms like Glassdoor or G2, making it difficult to assess workplace sentiment.
- Some general AI review platforms on Reddit express concerns about the accuracy and privacy of uploading medical data to online AI tools, though these are not specific to Brainreader.
- The available reviews are primarily focused on the product (Neuroreader) and are largely from medical/healthcare IT publications or studies, rather than direct user reviews on common software review sites.
- No self-serve pricing is mentioned for the product.
Based on reviews from: DOTmed.com, HealthTech Alpha, Blackford Analysis, BrainReader (company website), Journal of Alzheimer's Disease, Capterra, G2, Reddit
Last updated: 2026-06-19
Videos
News, demos, and interviews about Brainreader.
Videos load interactively. If none appear, search YouTube for Brainreader →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]